SCHEMBL30514972

SCHEMBL30514972

C[C@H]1CCC(c2ccc3sc(CC(C)(C)N(C)C)nc3c2)=NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25322588 1.00 — —
SCHEMBL25321474 1.00 — —
SCHEMBL29082027 0.89 LOXL2 (0.33) —
SCHEMBL24367600 0.84 HDAC6 (0.32) —
SCHEMBL30471172 0.84 HDAC6 (0.32) —
SCHEMBL24366026 0.84 HDAC6 (0.32) —
SCHEMBL32689101 0.84 HDAC6 (0.32) —
SCHEMBL32689015 0.83 HDAC6 (0.41) —
SCHEMBL24364976 0.83 HDAC6 (0.41) —
SCHEMBL29081633 0.83 HDAC6 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4469455-A1 COMPOUNDS AND METHODS OF USE Tango Therapeutics, Inc. (US) 2024-12-04 — — EP disclosed
EP-4469447-A1 COMPOUNDS AND METHODS OF USE Tango Therapeutics, Inc. (US) 2024-12-04 — — EP disclosed
WO-2023146990-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
WO-2023146989-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback